Data Vault

Labs

Structured lab results, grouped test panels, and longitudinal analyte trends for Levi.

Tracking 191 analytes (latest value):

Use this index as the first-pass evidence surface for cross-test reasoning, then open the cited source files or underlying records when exact report wording or uncaptured detail matters.

Stanford MyChart PDFs 01-32 are now extracted and normalized. Panels are consolidated by collection date to keep the index usable.

2026-04-17 Phase B audit - underlying records and normalized YAMLs for composite lab draws (2024-05-24, 2025-03-03, 2026-01-16, 2026-04-06 UCSF, 2026-04-06 CMP/lipid/hsCRP, 2026-04-07 pre-LP serum) have been extended with additional analyte rows, reference ranges, and per-panel metadata (including the 2026-04-06 UCSF-blood three transcription-error corrections - Hct 36.6, eosinophil abs 0.05, basophil abs 0.05). The key-findings summaries in this index already reflect the clinically significant values; use the linked normalized YAMLs for full analyte-level detail.

2026-04-18 EEG ingestion - the three EEG entries (2026-03-10 Stanford EMU, 2026-03-26 Stanford outpatient post-pulse, 2026-04-06 UCSF continuous) were previously status=pending with only case-overview-level summary content. They have been promoted to status=reviewed with verbatim-report-backed extracted records under content/vault/records/ and normalized session YAMLs under content/vault/normalized/eeg/sessions/. Lead-level foci, quantitative SWI values where stated, and the Lee-Messer MyChart correspondence are now preserved in the corpus.

2026-04-18 2024-baseline ingestion - added five new entries (Jan 24, 2024 Sutcliffe new-consult questionnaire; Apr 2, 2024 Sutcliffe behavior-therapy intake; Apr 9, 2024 baseline ABAS-3; May 12, 2024 ABA Initial Treatment Plan; May 24, 2024 Quest ClariSure OligoSNP CMA). The CMA closes a previously-open gap in the case overview ("CMA status unknown"). The ABAS-3 baseline makes the Apr->Nov 2024 GAC 69->58 trajectory visible. The May 12 plan corrects attribution of the "no regression of skills once learned" boilerplate from Nov 2024 (previously believed origin) to May 2024 (actual origin).

2026-04-20 OTEIM OT+SLP ingestion - added the Aug 22, 2025 OTEIM Comprehensive Neuroadaptive Therapy Evaluation & Treatment Plan (Erinn Askin OTR/L + Jillian Yudin CCC-SLP). First formal OT and SLP evaluation in the corpus. Establishes pre-DEE-SWAS SLP baseline (severely reduced speech intelligibility, absent oral-motor imitation, apraxia-like features, play primarily at exploratory/emerging functional levels), first on-file craniofacial-adjacent observations (prominent forehead, large ears, mild asymmetry), and first on-file documentation of guanfacine use. Audit flags preserved on the record for CAS (evaluator-attributed, not independently confirmed), the retained-primitive-reflex and hemispheric-weakness frameworks (not mainstream neurology), and the transcranial-LLLT adjunct (investigational; NOT to be initiated without epileptologist clearance given subsequent DEE-SWAS).

2026-04-20 Woodside IEP ingestion - added the 1/8/2026 Woodside Elementary annual IEP as a category-other record. First on-file IEP in the corpus. Establishes current educational placement (TK + SDC, 80/20 LRE, 420 min/day 1:1 aide), first on-file AAC device (iPad + TouchChat), prior-year goal outcomes (1 of 7 met), and BIP 2/13/2025 status. Two audit flags preserved on the underlying record - (a) Health section states "does not take any medication on a regular basis" contradicting OTEIM 8/22/2025 guanfacine documentation, and (b) Health section is stale relative to Jake's 4/20/2026 signature date (post-DEE-SWAS, post-steroid-pulse, post-near-clean UCSF EEG) with no amendment executed.

25-hydroxy vitamin D
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
25-Hydroxy D, Totalng/mL3725-80Normal
Albumin, serum/plasma (IgG index)
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Albumin, Plasma/Serumg/dL3.73.5-4.5Normal
Ammonia
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Ammoniaumol/L2916-68Normal
Autoimmune encephalitis / CNS disorder antibody panel
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
AMPA-R antibodyNegativeNormal
ANNA-1 (Anti-Hu)NegativeNormal
CASPR2 antibodyNegativeNormal
DPPX antibodyNegativeNormal
GABA-B-R antibodyNegativeNormal
GAD-65nmol/L0.00Normal
GFAP antibodyNegativeNormal
LGI1 antibodyNegativeNormal
mGluR1 antibodyNegativeNormal
MOG antibodyNegativeNormal
Neurochondrin antibodyNegativeNormal
NMDA-R antibodyNegativeNormal
NMO / Aquaporin-4 antibodyNegativeNormal
PCA-Tr (Anti-DNER)NegativeNormal
Basic metabolic panel
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Anion gapmEq/L115-15Normal
BUNmg/dL75-18Normal
Calciummg/dL9.58.8-10.8Normal
ChloridemEq/L10598-107Normal
CO2mEq/L2022-29Abnormal
Creatininemg/dL0.260.26-0.42Normal
Glucosemg/dL9370-100Normal
PotassiummEq/L4.83.5-5.5Normal
SodiummEq/L136135-145Normal
C-reactive protein, high sensitive (hsCRP)
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
High Sensitivity CRPmg/L<0.2<5.0Normal
CBC with auto-differential
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Basophil %%0.4Normal
Basophil absoluteK/uL0.070.090.050.00-0.30Normal
Basophil percent%0.7Normal
Eosinophil %%0.3Normal
Eosinophil absoluteK/uL0.170.070.050.00-1.10Normal
Eosinophil percent%1.8Normal
Hematocrit%38.73940.336.635.0-45.0Normal
Hemoglobing/dL12.212.412.911.611.4-15.5Normal
Immature granulocyte %%0.50.0 - 0.3Abnormal
Immature granulocyte absoluteK/uL0.010.02<0.10Normal
Immature granulocyte absoluteK/uL0.110.00 - 0.03Abnormal
Immature granulocyte percent%0.10.0-0.3Normal
Lymphocyte %%12.4Normal
Lymphocyte absoluteK/uL4.0532.241.20-8.00Normal
Lymphocyte percent%43.3Normal
MCHpg24.123.323.824.724.0-30.0Normal
MCHCg/dL31.531.83231.731.0-36.0Normal
MCVfL76.573.374.57875-87Normal
Mean platelet volume (MPV)fL10.39.1-12.6Normal
Monocyte %%5.5Normal
Monocyte absoluteK/uL0.951.340.850.00-1.40Normal
Monocyte percent%10.2Normal
Neutrophil %%80.9Normal
Neutrophil absoluteK/uL4.119.633.651.50-8.50Normal
Neutrophil percent%43.9Normal
nRBC %%0.0Normal
nRBC absoluteK/uL0.000.000.0<=0.0Normal
nRBC percent%0.0Normal
Platelet countK/uL370389334279140-450Normal
RBCM/uL5.065.325.414.693.90-4.90Normal
RDW%14.212.812.911.5 - 14.5Normal
RDW-CV%12.811.7-14.4Normal
WBCK/uL9.45.124.26.94.5-15.5Normal
Creatine disorder panel (creatine and guanidinoacetic acid)
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Creatinenmol/mL7110 - 120Normal
Guanidinoacetic acidnmol/mL1.40.0 - 3.0Normal
Cytokine Panel 13 - Serum (ARUP)
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Interferon gammapg/mL12.7<=4.2Abnormal
Interleukin 1 betapg/mL<6.5<=6.7Normal
Interleukin 10pg/mL<2.8<=2.8Normal
Interleukin 12pg/mL<1.9<=1.9Normal
Interleukin 13pg/mL4.0<=2.3Abnormal
Interleukin 17pg/mL1.8<=1.4Abnormal
Interleukin 2pg/mL<2.1<=2.1Normal
Interleukin 2 Receptor, soluble (sIL-2R)pg/mL1031.4175.3-858.2Abnormal
Interleukin 4pg/mL<2.2<=2.2Normal
Interleukin 5pg/mL<2.1<=2.1Normal
Interleukin 6pg/mL<2.0<=2.0Normal
Interleukin 8pg/mL<3.0<=3.0Normal
Tumor Necrosis Factor alpha (TNF-alpha)pg/mL13.3<=7.2Abnormal
Ferritin
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Ferritinng/mL35.62714-79Normal
Folate and thyroid antibody screen
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Folate, serumng/mL34.8>=11.9Normal
Thyroglobulin antibodiesIU/mL<2.00<2.00Normal
Thyroperoxidase antibodiesWHO Units<63<=100Normal
Fragile X FMR1 CGG repeat analysis
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
FMR1 CGG repeatsrepeats33<44Normal
Glucose, fasting
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Glucose, Fasting, Plasma/Serummg/dL8870-99Normal
Homocysteine, total
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Homocysteine, totalumol/L7.3<15.0Normal
Iron, % saturation, and transferrin (TIBC)
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Ferritinng/mL6630 - 400Normal
Ironug/dL7845165616-128Normal
TIBCug/dL390371250-425Normal
Transferrin % Saturation%137-39Normal
Transferrin saturation%201220-60Abnormal
Transferrin, Plasma/Serummg/dL313220-337Normal
Lactate, plasma
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Lactate, plasmammol/L0.91.0-2.4Abnormal
Lead level
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Leadug/dL<2.0<3.5Normal
Lipid panel
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Cholesterol, Totalmg/dL159143<170Normal
Cholesterol/HDL ratioratio2.5<5.0Normal
Cholesterol/HDL Ratioratio3.0<6.0Normal
HDL Cholesterolmg/dL6348>45Normal
LDL Calculated (NIH)mg/dL8043<110Normal
LDL/HDL ratioratio1.3<3.0Normal
Non HDL Cholesterolmg/dL95<120Normal
Non-HDL Chol, Calcmg/dL96<160Normal
Triglyceride, Ser/Plasmg/dL86262<75Abnormal
Metabolic panel, comprehensive
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Albuming/dL3.33.5-4.5Abnormal
Alkaline phosphataseU/L217156-369Normal
ALTU/L149-25Normal
Anion gapmmol/L94-14Normal
ASTU/L2321-44Normal
BUNmg/dL99-22Normal
Calciummg/dL9.39.2-10.5Normal
Chloridemmol/L107101-110Normal
CO2mmol/L2117-26Normal
Creatininemg/dL0.290.31-0.61Abnormal
eGFRmL/min/1.73m2No valueNormal
Globuling/dL2.82.0-5.0Normal
Glucose (non-fasting)mg/dL11356-145Normal
Potassiummmol/L3.53.5-5.0Normal
Sodiummmol/L137135-145Normal
Total bilirubinmg/dL0.30.1-0.4Normal
Total proteing/dL6.56.1-7.5Normal
Methylmalonic acid
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Methylmalonic acidumol/L0.240.00 - 0.30Normal
Osmolality, serum
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Osmolality, serummOsm/kg295285-310Normal
Osmolality, urine
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Osmolality, urinemOsm/kg480300-900Normal
Plasma acylcarnitines, quantitative
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
C10, Decanoylcarnitineumol/L0.080.02 - 0.90Normal
C10:1, Decenoylcarnitineumol/L0.040.01 - 0.45Normal
C12-OH, 3OH-Dodecanoylcarnitineumol/L0.010.00 - 0.08Normal
C12, Dodecanoylcarnitineumol/L0.020.02 - 0.34Normal
C12:1, Dodecenoylcarnitineumol/L0.020.00 - 0.36Normal
C14-OH, 3OH-Tetradecanoylcarnitineumol/L00.00 - 0.04Normal
C14, Tetradecanoylcarnitineumol/L0.010.01 - 0.14Normal
C14:1-OH, 3OH-Tetradecenoylcarnitineumol/L0.010.00 - 0.17Normal
C14:1, Tetradecenoylcarnitineumol/L0.030.01 - 0.34Normal
C14:2, Tetradecadienoylcarnitineumol/L0.010.01 - 0.12Normal
C16-OH, 3OH-Palmitoylcarnitineumol/L0.010.00 - 0.06Normal
C16, Palmitoylcarnitineumol/L0.070.04 - 0.51Normal
C16:1-OH, 3OH-Palmitoleylcarnitineumol/L0.010.00 - 0.35Normal
C16:1, Palmitoleylcarnitineumol/L0.020.00 - 0.20Normal
C18, Stearoylcarnitineumol/L0.030.01 - 0.11Normal
C18:1-OH, 3OH-Oleylcarnitineumol/L00.00 - 0.03Normal
C18:1, Oleylcarnitineumol/L0.060.03 - 0.44Normal
C18:2-OH, 3OH-Linoleylcarnitineumol/L00.00 - 0.05Normal
C18:2, Linoleylcarnitineumol/L0.030.00 - 0.30Normal
C2, Acetylcarnitineumol/L3.680.31 - 14.96Normal
C3, Propionylcarnitineumol/L0.320.08 - 1.77Normal
C4, Isobutyrylcarnitine/Butyrylcarnitineumol/L0.140.06 - 1.05Normal
C5-DC, Glutarylcarnitineumol/L0.020.00 - 0.10Normal
C5-OH, 3OH-Isovalerylcarnitineumol/L0.030.01 - 0.11Normal
C5, Isovalerylcarnitine/2-Methylbutyrylcarnitineumol/L0.070.05 - 0.62Normal
C6-OH, 3OH-Hexanoylcarnitineumol/L0.010.00 - 0.18Normal
C6, Hexanoylcarnitineumol/L0.030.01 - 0.22Normal
C8, Octanoylcarnitineumol/L0.050.01 - 0.44Normal
C8:1, Octenoylcarnitineumol/L0.160.02 - 0.90Normal
Plasma acylcarnitine profile interpretationNormal plasma acylcarnitine profileNormal
Plasma amino acids, quantitative
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
a-Aminoadipic acidnmol/mL10 - 6Normal
a-Aminobutyric acidnmol/mL94 - 31Normal
Alaninenmol/mL330152 - 547Normal
Argininenmol/mL5810 - 140Normal
Asparaginenmol/mL3918 - 95Normal
Aspartic acidnmol/mL33 - 45Normal
b-Alaninenmol/mL10 - 10Normal
b-Aminoisobutyric acidnmol/mL10 - 12Normal
Citrullinenmol/mL261 - 46Normal
Cystathioninenmol/mL00 - 5Normal
Cystinenmol/mL275 - 45Normal
Ethanolaminenmol/mL80 - 17Normal
Glutamic acidnmol/mL395 - 150Normal
Glutaminenmol/mL498254 - 823Normal
Glycinenmol/mL310127 - 341Normal
Histidinenmol/mL6241 - 125Normal
Homocysteine (plasma amino acid panel)nmol/mL0<1Normal
Hydroxyprolinenmol/mL140 - 45Normal
Isoleucinenmol/mL5622 - 107Normal
Leucinenmol/mL10449 - 216Normal
Lysinenmol/mL11448 - 284Normal
Methioninenmol/mL177 - 47Normal
Ornithinenmol/mL3810 - 163Normal
Phenylalaninenmol/mL5926 - 91Normal
Plasma amino acid pattern interpretationNormal pattern of amino acids for ageNormal
Prolinenmol/mL21559 - 369Normal
Sarcosinenmol/mL30 - 3Normal
Serinenmol/mL9769 - 187Normal
Taurinenmol/mL5910 - 170Normal
Threoninenmol/mL9435 - 226Normal
Tryptophannmol/mL580 - 79Normal
Tyrosinenmol/mL6524 - 115Normal
Valinenmol/mL18974 - 321Normal
Serum immunoglobulins
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
IgAmg/dL4427-195Normal
IgE, totalIU/mL<21<60Normal
IgGmg/dL518532-1340Abnormal
IgMmg/dL9326-188Normal
Thyroid function (Free T3, Free T4, TSH)
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Free T3pg/mL4.82.0 - 6.0Normal
Free T4ng/dL1.170.90 - 1.70Normal
TSHuIU/mL2.072.360.27 - 4.20Normal
Uric acid
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Uric acidmg/dL4.22.0 - 6.5Normal
Vitamin B12
TestUnitMay 24, 2024Mar 3, 2025Jan 16, 2026Mar 23, 2026Apr 6, 2026Apr 7, 2026RefLatest
Vitamin B12pg/mL908528232 - 1245Normal